SCHEMBL25661986

SCHEMBL25661986

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1nc(-c2ccccc2)nc(-n2c3ccc(C)cc3c3cc(C)ccc32)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NLRP3 Q96P20 1/20 0.43
▸ ADORA3 P0DMS8 3/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ ADORA2A P29274 1/20 0.43
▸ ADORA1 P30542 1/20 0.43
▸ LMNA P02545 5/20 0.42
▸ KDM4E B2RXH2 4/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ MAPT P10636 4/20 0.42
▸ MEN1 O00255 4/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ NR1I2 O75469 1/20 0.41
▸ AHR P35869 1/20 0.41
▸ NPC1 O15118 1/20 0.40
▸ GBA1 P04062 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ ABCG2 Q9UNQ0 2/20 0.40
▸ DHODH Q02127 1/20 0.40
▸ ABCB1 P08183 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30118239 0.92 L3MBTL1 (0.43) NLRP3ADORA3L3MBTL1ADORA2AADORA1
SCHEMBL10052463 0.92 L3MBTL1 (0.43) NLRP3ADORA3L3MBTL1ADORA2AADORA1
SCHEMBL15026022 0.92 CYP1A1 (0.40) NLRP3ADORA3ADORA2AADORA1LMNA
SCHEMBL12033584 0.90 L3MBTL1 (0.41) NLRP3ADORA3L3MBTL1ADORA2AADORA1
SCHEMBL21515577 0.89 L3MBTL1 (0.40) NLRP3ADORA3L3MBTL1ADORA2AADORA1
SCHEMBL12132277 0.89 CYP1A1 (0.40) NLRP3ADORA3L3MBTL1ADORA2AADORA1
SCHEMBL23373492 0.88 NR1I3 (0.41) NLRP3ADORA3ADORA2AADORA1LMNA
SCHEMBL21515578 0.87 L3MBTL1 (0.39) NLRP3ADORA3L3MBTL1ADORA2AADORA1
SCHEMBL12033733 0.87 DHODH (0.40) NLRP3ADORA3L3MBTL1ADORA2AADORA1
SCHEMBL17691595 0.87 AVPR1A (0.39) NLRP3ADORA3L3MBTL1ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150982-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER LT MATERIALS CO., LTD. (KR) 2023-05-18 — — US disclosed
US-20230150982-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER LT MATERIALS CO., LTD. (KR) 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150982-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER CYP1B1, NOTUM, ORMDL3 NLRP3 331/4885ADORA3 4186/4885L3MBTL1 1652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback